5. Conclusion
In summary, the network pharmacology approach was performed to unveil
the chemical basis and investigate the action mechanism of
TwHF on CVD. 51 active compounds
of TwHF and 5 core target genes of TwHF against CVD, including AKT1,
APP, MAPK, PIK3CA and TP53 were identified. Based on the analysis of GO
and KEGG, cancer pathway was found to be closely associated with the
protective effect of TwHF on CVD. The present study provides a
theoretical basis and a clue for the pharmacological mechanism study of
TwHF on CVD. However, further experimental studies of these prediction
results are needed to validate potential application.
1. Olvera Lopez E, Ballard BD, Jan A: Cardiovascular Disease .
In: StatPearls. Treasure Island (FL): StatPearls Publishing
Copyright © 2020, StatPearls Publishing LLC.; 2020.
2. Dunbar SB, Khavjou OA, Bakas T, Hunt G, Kirch RA, Leib AR, Morrison
RS, Poehler DC, Roger VL, Whitsel LP: Projected Costs of
Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy
Statement From the American Heart Association . Circulation 2018,137 (19):e558-e577.
3. Bansilal S, Castellano JM, Fuster V: Global burden of CVD:
focus on secondary prevention of cardiovascular disease .International journal of cardiology 2015, 201 Suppl
1 :S1-7.
4. Joseph P, Leong D, McKee M, Anand SS, Schwalm JD, Teo K, Mente A,
Yusuf S: Reducing the Global Burden of Cardiovascular Disease,
Part 1: The Epidemiology and Risk Factors . Circulation research2017, 121 (6):677-694.
5. Leong DP, Joseph PG, McKee M, Anand SS, Teo KK, Schwalm JD, Yusuf S:Reducing the Global Burden of Cardiovascular Disease, Part 2:
Prevention and Treatment of Cardiovascular Disease . Circulation
research 2017, 121 (6):695-710.
6. Hao P, Jiang F, Cheng J, Ma L, Zhang Y, Zhao Y: Traditional
Chinese Medicine for Cardiovascular Disease: Evidence and Potential
Mechanisms . Journal of the American College of Cardiology 2017,69 (24):2952-2966.
7. Zhao X, Liu Z, Ren Z, Wang H, Wang Z, Zhai J, Cao D, Lyu S, Li L,
Lang R et al : Triptolide inhibits pancreatic cancer cell
proliferation and migration via down-regulating PLAU based on network
pharmacology of Tripterygium wilfordii Hook F . European journal
of pharmacology 2020, 880 :173225.
8. Xue M, Jiang ZZ, Wu T, Li J, Zhang L, Zhao Y, Li XJ, Zhang LY, Yang
SY: Anti-inflammatory effects and hepatotoxicity of
Tripterygium-loaded solid lipid nanoparticles on adjuvant-induced
arthritis in rats . Phytomedicine : international journal of
phytotherapy and phytopharmacology 2012, 19 (11):998-1006.
9. Choi BS, Sapkota K, Kim S, Lee HJ, Choi HS, Kim SJ:Antioxidant activity and protective effects of Tripterygium
regelii extract on hydrogen peroxide-induced injury in human
dopaminergic cells, SH-SY5Y . Neurochemical research 2010,35 (8):1269-1280.
10. Peng WH, Chen GL, Zhou Y, Fan SY, Fu DL, Wang Y: Study of
expression of circulating inflammatory factors in ACS rats with low dose
of Tripterygium Wilfordii . Hellenic journal of cardiology : HJC =
Hellenike kardiologike epitheorese 2018, 59 (1):46-47.
11. Li X, Wu N, Zou L, Jia D: Protective effect of celastrol on
myocardial ischemia-reperfusion injury . Anatolian journal of
cardiology 2017, 18 (6):384-390.
12. Li R, Lu K, Wang Y, Chen M, Zhang F, Shen H, Yao D, Gong K, Zhang Z:Triptolide attenuates pressure overload-induced myocardial
remodeling in mice via the inhibition of NLRP3 inflammasome expression .Biochemical and biophysical research communications 2017,485 (1):69-75.
13. Yu H, Shi L, Zhao S, Sun Y, Gao Y, Sun Y, Qi G: Triptolide
Attenuates Myocardial Ischemia/Reperfusion Injuries in Rats by Inducing
the Activation of Nrf2/HO-1 Defense Pathway . Cardiovascular
toxicology 2016, 16 (4):325-335.
14. Lu C, Yu X, Zuo K, Zhang X, Cao C, Xu J, Wang S, Tang T, Ye M, Pei Eet al : Tripterine treatment improves endothelial
progenitor cell function via integrin-linked kinase . Cellular
physiology and biochemistry : international journal of experimental
cellular physiology, biochemistry, and pharmacology 2015,37 (3):1089-1103.
15. Han B, Ge CQ, Zhang HG, Zhou CG, Ji GH, Yang Z, Zhang L:Effects of tripterygium glycosides on restenosis following
endovascular treatment . Molecular medicine reports 2016,13 (6):4959-4968.
16. Hopkins AL: Network pharmacology . Nature
biotechnology 2007, 25 (10):1110-1111.
17. Lu C, Bing Z, Bi Z, Liu M, Lu T, Xun Y, Wei Z, Yang K:Top-100 Most Cited Publications Concerning Network Pharmacology:
A Bibliometric Analysis . Evidence-based complementary and
alternative medicine : eCAM 2019, 2019 :1704816.
18. Li P, Chen J, Wang J, Zhou W, Wang X, Li B, Tao W, Wang W, Wang Y,
Yang L: Systems pharmacology strategies for drug discovery and
combination with applications to cardiovascular diseases . Journal
of ethnopharmacology 2014, 151 (1):93-107.
19. Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang
Y et al : TCMSP: a database of systems pharmacology for
drug discovery from herbal medicines . Journal of cheminformatics2014, 6 :13.
20. Liu F, Li Y, Li M, Wang J, Zhang Y, Du Y, Yang Y: Study on
Mechanism of Iridoid Glycosides Derivatives from Fructus Gardeniae in
Jiangxi Province by Network Pharmacology . Evidence-based
complementary and alternative medicine : eCAM 2020,2020 :4062813.
21. Huang L, Xie D, Yu Y, Liu H, Shi Y, Shi T, Wen C: TCMID 2.0:
a comprehensive resource for TCM . Nucleic acids research 2018,46 (D1):D1117-d1120.
22. Xu J, Wang F, Guo J, Xu C, Cao Y, Fang Z, Wang Q:Pharmacological Mechanisms Underlying the Neuroprotective
Effects of Alpinia oxyphylla Miq. on Alzheimer’s Disease .International journal of molecular sciences 2020, 21 (6).
23. Daina A, Michielin O, Zoete V: SwissTargetPrediction:
updated data and new features for efficient prediction of protein
targets of small molecules . Nucleic acids research 2019,47 (W1):W357-w364.
24. Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T,
Johnson D, Li C, Sayeeda Z et al : DrugBank 5.0: a major
update to the DrugBank database for 2018 . Nucleic acids research2018, 46 (D1):D1074-d1082.
25. Amberger JS, Hamosh A: Searching Online Mendelian
Inheritance in Man (OMIM): A Knowledgebase of Human Genes and Genetic
Phenotypes . Current protocols in bioinformatics 2017,58 :1.2.1-1.2.12.
26. Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S,
Stein TI, Nudel R, Lieder I, Mazor Y et al : The GeneCards
Suite: From Gene Data Mining to Disease Genome Sequence Analyses .Current protocols in bioinformatics 2016,54 :1.30.31-31.30.33.
27. Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D,
Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP et al :STRING v10: protein-protein interaction networks, integrated
over the tree of life . Nucleic acids research 2015,43 (Database issue):D447-452.
28. Blake JA CK, Dolan ME, Drabkin HJ, Hill DP, Ni L, Sitnikov D,
Burgess S, Buza T, Gresham C, McCarthy F: Gene Ontology
Consortium: going forward . Nucleic acids research 2015,43 (Database issue):D1049-1056.
29. Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K:KEGG: new perspectives on genomes, pathways, diseases and
drugs . Nucleic acids research 2017, 45 (D1):D353-d361.
30. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N,
Schwikowski B, Ideker T: Cytoscape: a software environment for
integrated models of biomolecular interaction networks . Genome
research 2003, 13 (11):2498-2504.
31. Li R, Guo C, Li Y, Qin Z, Huang W: Therapeutic targets and
signaling mechanisms of vitamin C activity against sepsis: a
bioinformatics study . Briefings in bioinformatics 2020.
32. Zhang J, Li H, Zhang Y, Zhao C, Zhu Y, Han M: Uncovering the
Pharmacological Mechanism of Stemazole in the Treatment of
Neurodegenerative Diseases Based on a Network Pharmacology Approach .International journal of molecular sciences 2020, 21 (2).
33. Song X, Zhang Y, Dai E, Wang L, Du H: Prediction of
triptolide targets in rheumatoid arthritis using network pharmacology
and molecular docking . International immunopharmacology 2020,80 :106179.
34. Zhou W, Wang Y, Lu A, Zhang G: Systems Pharmacology in Small
Molecular Drug Discovery . International journal of molecular
sciences 2016, 17 (2):246.
35. Ye S, Luo W, Khan ZA, Wu G, Xuan L, Shan P, Lin K, Chen T, Wang J,
Hu X et al : Celastrol Attenuates Angiotensin II-Induced
Cardiac Remodeling by Targeting STAT3 . Circulation research2020, 126 (8):1007-1023.
36. Der Sarkissian S, Cailhier JF, Borie M, Stevens LM, Gaboury L,
Mansour S, Hamet P, Noiseux N: Celastrol protects ischaemic
myocardium through a heat shock response with up-regulation of haeme
oxygenase-1 . British journal of pharmacology 2014,171 (23):5265-5279.
37. Cheng M, Wu G, Song Y, Wang L, Tu L, Zhang L, Zhang C:Celastrol-Induced Suppression of the MiR-21/ERK Signalling
Pathway Attenuates Cardiac Fibrosis and Dysfunction . Cellular
physiology and biochemistry : international journal of experimental
cellular physiology, biochemistry, and pharmacology 2016,38 (5):1928-1938.
38. Liu F, Zhang H, Li Y, Lu X: Nobiletin suppresses oxidative
stress and apoptosis in H9c2 cardiomyocytes following
hypoxia/reoxygenation injury . European journal of pharmacology2019, 854 :48-53.
39. Zhang BF, Jiang H, Chen J, Guo X, Li Y, Hu Q, Yang S:Nobiletin ameliorates myocardial ischemia and reperfusion injury
by attenuating endoplasmic reticulum stress-associated apoptosis through
regulation of the PI3K/AKT signal pathway . International
immunopharmacology 2019, 73 :98-107.
40. Guo X, Xue M, Li CJ, Yang W, Wang SS, Ma ZJ, Zhang XN, Wang XY, Zhao
R, Chang BC et al : Protective effects of triptolide on
TLR4 mediated autoimmune and inflammatory response induced myocardial
fibrosis in diabetic cardiomyopathy . Journal of
ethnopharmacology 2016, 193 :333-344.
41. Liang Z, Leo S, Wen H, Ouyang M, Jiang W, Yang K: Triptolide
improves systolic function and myocardial energy metabolism of diabetic
cardiomyopathy in streptozotocin-induced diabetic rats . BMC
cardiovascular disorders 2015, 15 :42.
42. Negrão R, Duarte D, Costa R, Soares R: Isoxanthohumol
modulates angiogenesis and inflammation via vascular endothelial growth
factor receptor, tumor necrosis factor alpha and nuclear factor kappa B
pathways . BioFactors (Oxford, England) 2013,39 (6):608-622.
43. Li C, Liu Y, Xie Z, Lu Q, Luo S: Stigmasterol protects
against Ang II-induced proliferation of the A7r5 aortic smooth muscle
cell-line . Food & function 2015, 6 (7):2266-2272.
44. Feng H, Cao J, Zhang G, Wang Y: Kaempferol Attenuates
Cardiac Hypertrophy via Regulation of ASK1/MAPK Signaling Pathway and
Oxidative Stress . Planta medica 2017, 83 (10):837-845.
45. Zhang L, Guo Z, Wang Y, Geng J, Han S: The protective effect
of kaempferol on heart via the regulation of Nrf2, NF-κβ, and
PI3K/Akt/GSK-3β signaling pathways in isoproterenol-induced heart
failure in diabetic rats . Drug development research 2019,80 (3):294-309.
46. Abeyrathna P, Su Y: The critical role of Akt in
cardiovascular function . Vascular pharmacology 2015,74 :38-48.
47. Yu G, Luo Z, Zhou Y, Zhang L, Wu Y, Ding L, Shi Y:Uncovering the pharmacological mechanism of Carthamus tinctorius
L. on cardiovascular disease by a systems pharmacology approach .Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2019, 117 :109094.
48. Leevers SJ, Vanhaesebroeck B, Waterfield MD: Signalling
through phosphoinositide 3-kinases: the lipids take centre stage .Current opinion in cell biology 1999, 11 (2):219-225.
49. Carpenter CL, Duckworth BC, Auger KR, Cohen B, Schaffhausen BS,
Cantley LC: Purification and characterization of
phosphoinositide 3-kinase from rat liver . The Journal of
biological chemistry 1990, 265 (32):19704-19711.
50. McLean BA, Patel VB, Zhabyeyev P, Chen X, Basu R, Wang F, Shah S,
Vanhaesebroeck B, Oudit GY: PI3Kα Pathway Inhibition With
Doxorubicin Treatment Results in Distinct Biventricular Atrophy and
Remodeling With Right Ventricular Dysfunction . Journal of the
American Heart Association 2019, 8 (9):e010961.
51. Network CGA: Comprehensive molecular portraits of human
breast tumours . Nature 2012, 490 (7418):61-70.
52. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman
K, Cobb MH: Mitogen-activated protein (MAP) kinase pathways:
regulation and physiological functions . Endocrine reviews 2001,22 (2):153-183.
53. Wang Y, Zhang X, Gao L, Li J, Chen W, Chi J, Zhang X, Fu Y, Zhao M,
Liu N et al : Cortistatin exerts antiproliferation and
antimigration effects in vascular smooth muscle cells stimulated by Ang
II through suppressing ERK1/2, p38 MAPK, JNK and ERK5 signaling
pathways . Annals of translational medicine 2019,7 (20):561.
54. Taniyama Y, Ushio-Fukai M, Hitomi H, Rocic P, Kingsley MJ, Pfahnl C,
Weber DS, Alexander RW, Griendling KK: Role of p38 MAPK and
MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth
muscle cells . American journal of physiology Cell physiology2004, 287 (2):C494-499.
55. Kyotani Y, Zhao J, Tomita S, Nakayama H, Isosaki M, Uno M, Yoshizumi
M: Olmesartan inhibits angiotensin II-Induced migration of
vascular smooth muscle cells through Src and mitogen-activated protein
kinase pathways . Journal of pharmacological sciences 2010,113 (2):161-168.
56. Visconte C, Canino J, Guidetti GF, Zarà M, Seppi C, Abubaker AA,
Pula G, Torti M, Canobbio I: Amyloid precursor protein is
required for in vitro platelet adhesion to amyloid peptides and
potentiation of thrombus formation . Cellular signalling 2018,52 :95-102.
57. Canobbio I, Visconte C, Momi S, Guidetti GF, Zarà M, Canino J,
Falcinelli E, Gresele P, Torti M: Platelet amyloid precursor
protein is a modulator of venous thromboembolism in mice . Blood2017, 130 (4):527-536.
58. Kolovou V, Tsipis A, Mihas C, Katsiki N, Vartela V, Koutelou M,
Manolopoulou D, Leondiadis E, Iakovou I, Mavrogieni S et al :Tumor Protein p53 (TP53) Gene and Left Main Coronary Artery
Disease . Angiology 2018, 69 (8):730-735.
59. Tiwari S, Dwivedi UN: Discovering Innovative Drugs Targeting
Both Cancer and Cardiovascular Disease by Shared Protein-Protein
Interaction Network Analyses . Omics : a journal of integrative
biology 2019, 23 (9):417-425.
60. Ivanov AA, Khuri FR, Fu H: Targeting protein-protein
interactions as an anticancer strategy . Trends in pharmacological
sciences 2013, 34 (7):393-400.
61. Sarajlić A, Janjić V, Stojković N, Radak D, Pržulj N:Network topology reveals key cardiovascular disease genes .PloS one 2013, 8 (8):e71537.
62. Zhang C, He XJ, Li L, Lu C, Lu AP: Effect of the Natural
Product Triptolide on Pancreatic Cancer: A Systematic Review of
Preclinical Studies . Frontiers in pharmacology 2017,8 :490.
63. Wen L, Chen Y, Zeng LL, Zhao F, Yi S, Yang LJ, Zhang BP, Zhao J,
Zhao ZC, Zhang C: Triptolide Induces Cell Apoptosis by Targeting
H3K4me3 and Downstream Effector Proteins in KM3 Multiple Myeloma Cells .Current pharmaceutical biotechnology 2015,17 (2):147-160.
64. Fuchs O: Transcription factor NF-κB inhibitors as single
therapeutic agents or in combination with classical chemotherapeutic
agents for the treatment of hematologic malignancies . Current
molecular pharmacology 2010, 3 (3):98-122.